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Aim. Our aims were to determine the influence of plasma total 25-hydroxy vitamin D (25(OH)D) status on the plasma cytokine
concentrations in athletes and the in vitro effects of different doses of 1, 25 dihydroxyvitamin D
3
(1, 25(OH)
2
D
3
) on multiantigen
stimulated cytokine production by whole blood and peripheral bloodmononuclear cell (PBMC) cultures.Methods. Plasma samples
from 43 athletes with high and low levels of 25(OH)D were assayed for the concentrations of cytokines. The whole blood samples
and PBMCs from healthy subjects were incubated in vitro with a multi-antigen vaccine and different doses of added 1, 25(OH)
2
D
3
.
The circulating cytokines and stimulated whole blood and PBMC culture production of cytokines were determined using a biochip
assay. Results. The circulating interleukin-(IL-)10 and interferon-(IFN-) 𝛾 concentrations were significantly higher in the vitamin
D sufficient athletes. Furthermore, the production of tumour necrosis factor-(TNF-) 𝛼, IL-6, IFN-𝛾, IL-2, and IL-10 by whole blood
culture was significantly inhibited by 1, 25(OH)
2
D
3
concentrations of 1000 pmol/L or 10000 pmol/L.Conclusions. We found that the
influence of vitamin D on circulating cytokines might be different in athletes compared with nonathletes and cytokines production
by whole blood culture was not influenced by 1, 25(OH)
2
D
3
in concentrations within the normal healthy range.
1. Introduction
Vitamin D can be obtained either from dietary sources or
the epidermal layer of the skin via exposure to sunlight.
The endogenously synthesised vitamin D
3
and diet-derived
D
2
and D
3
are hydroxylated in the liver to form 25(OH)D.
25(OH)D is the main storage form, which can be stored
in muscles and adipose tissue, and is the major circulating
metabolite of vitamin D, with a plasma half-life of 2-3
weeks. Therefore, the plasma concentration of 25(OH)D is
considered to be the primary indicator of vitaminD status [1].
Plasma 25(OH)D values commonly accepted as the reference
range [2] are as follows. In healthy humans, 25(OH)D >
100 nmol/L are defined as optimal vitamin D status and levels
from 50 to 100 nmol/L are defined as adequate. Plasma levels
of 25(OH)D < 50 nmol/L are proposed to define inadequate
vitamin D status and values < 30 nmol/L represent vitamin D
deficiency. Subsequently, 25(OH)D can be converted in the
kidney to the biologically active form, 1, 25(OH)
2
D, by 1-𝛼-
hydroxylase, an enzyme which is stimulated by parathyroid
hormonewhen serum calcium and phosphate concentrations
fall below the physiological range. Normal concentrations of
circulating 1, 25(OH)
2
D are approximately 50–250 pmol/L,
about 1000 times lower than its precursor, 25(OH)D; the
plasma half-life of 1, 25(OH)
2
D is 4–6 hours [3].
It has only recently been recognised that vitamin D plays
an important role in upregulating immunity [4]. Several
recent studies have found a negative association between
vitamin D status and respiratory illness incidence in young
and elderly adults and it has been indicated that individuals
with low vitamin D status have a higher risk of respiratory
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illness incidence and suffer more severe symptoms when a
respiratory illness is present [5–7]. Moreover, the presence of
the vitamin D receptor in almost all immune cells, including
T lymphocytes, B lymphocytes, neutrophils, and antigen
presenting cells, such as macrophages and dendritic cells
has been demonstrated and these immune cells also express
the vitamin D-activating enzyme, 1-𝛼-hydroxylase, and thus
possess the ability to convert 25(OH)D to 1, 25(OH)
2
D. This
process is regulated by circulating levels of 25(OH)D or
induced by activation of specific toll-like receptors which
act as detectors of pathogens [1, 8]. Therefore, vitamin D
could play vital roles in both innate and adaptive immune
responses.
Furthermore, vitamin D may also influence circulating
cytokine levels and cytokine production during periods of
infection.Within the general population it has been reported
that circulating proinflammatory cytokine concentrations,
such as TNF-𝛼, IFN-𝛾, IL-1𝛽, and IL-2, were significantly
higher in vitamin D insufficient adults compared with those
who were vitamin D sufficient [9]. However, to our knowl-
edge, there has been no study to compare the difference in
circulating cytokine levels between vitaminD insufficient and
sufficient athletes. Moreover, the anti-inflammatory effects of
exercise training [10] might modify the influence of plasma
25(OH)D on circulating cytokine levels in athletes. Thus, it
is of interest to determine the influence of plasma 25(OH)D
status on circulating cytokine levels in athletes. In addition,
several recent studies indicate that 1, 25(OH)
2
D
3
limits the
in vitro production of TNF-𝛼, IFN-𝛾, and IL-6 by isolated
human PBMC stimulated with lipopolysaccharide (LPS)
and Candida albicans and seasonal variations in vitamin D
levels correlate with alterations in cytokine production by
ex vivo LPS stimulated PBMC, with higher TNF-𝛼, IFN-
𝛾, and IL-6 production in winter [11, 12]. Nevertheless, in
our previous vitamin D study [7], we found that vitamin D
deficiencywas associatedwith substantially lower production
of proinflammatory cytokines, such as TNF-𝛼, IFN-𝛾, IL-
1𝛽, and IL-6, in the whole blood culture by both monocytes
and lymphocytes in response to a multiantigen challenge
containing antigens from a virus and both gram-positive and
gram-negative bacteria. The reason for this discrepancy is
unclear and further research is still needed to understand the
influence of vitamin D on multi-antigen stimulated cytokine
production.
In the present study, our aims were to determine the
influence of plasma 25(OH)D status on the plasma cytokine
concentrations of endurance sport athletes and the effects of
different doses of 1, 25(OH)
2
D
3
on the in vitromulti-antigen
stimulated cytokine production by whole blood and PBMC
cultures.
2. Methods
2.1. Participants. A total of 225 healthy individuals engaged
in regular sports training (predominantly endurance-based
activities such as running, cycling, swimming, triathlon,
team games, and racquet sports) were recruited as subjects
from Loughborough University, UK (latitude 53∘N), during
November 2011, in our previous vitamin D study [7] with
the mean age of the study cohort at recruitment being
21 ± 3 years (mean ± SD) and their self-reported training
loads averaged 10 h/week. Subjects were required to complete
a comprehensive health-screening questionnaire prior to
starting the study and had not taken any regular medication
or antibiotics in the 3 months prior to the study. All subjects
were fully informed about the rationale for the study and
of all experimental procedures to be undertaken. Subjects
provided written consent to participate in the study, which
had earlier received the approval of LoughboroughUniversity
Ethical Advisory Committee. For the visit to the laboratory,
subjects arrived in the morning at 08:30–10:30 following an
overnight fast of approximately 12 h and their body mass
and height were recorded. Information about the study was
given to them and they then signed an informed consent
form. Subsequently, a resting venous blood sample (5mL)
was obtained by venepuncture from an antecubital forearm
vein into a vacutainer tube (Becton Dickinson, Oxford, UK)
containing K
3
EDTA. Haematological analysis was immedi-
ately carried out on this sample (including haemoglobin,
haematocrit, and total and differential leukocyte counts)
using an automated cell-counter (Ac.T 5diff haematology
analyser, Beckman Coulter, High Wycombe, UK). Subjects
had to have normal haematology to be included in the study.
The remaining EDTA blood was centrifuged for 10min at
1500 g and 4∘C and the plasma was stored at −80∘C prior to
analysis. EDTA plasma samples from 43 athletes with high
and low vitamin D status (high level: 25(OH)D > 80 nmol/L,
𝑛 = 18; low level: 25(OH)D < 40 nmol/L, 𝑛 = 25) with
sufficient volume were selected for assay of the circulating
cytokine concentrations. There was no significant difference
in the physical characteristics of participants between high-
level and low-level vitamin D status groups (Table 1).
For the study of 1, 25(OH)
2
D
3
in vitro incubation, 6
healthy male individuals (age: 28.8 ± 4.1; height: 176.3 ± 10.0;
weight: 83.9 ± 7.8; BMI: 27.1 ± 2.9) who had not taken
any regular medication or antibiotics in the 3 months prior
to the study were recruited as subjects from Loughborough
University. For the visit to the laboratory, subjects arrived
in the morning at 08:30–10:30 following an overnight fast
of approximately 12 h and subsequently, a resting venous
blood sample (20mL) was obtained by venepuncture from
an antecubital forearm vein into vacutainer tubes contain-
ing K
3
EDTA and lithium heparin. Haematological analysis
was immediately carried out on the EDTA sample using
an automated cell counter. Subjects had to have normal
haematology to be included in the study. The whole blood
samples and the PBMC isolated from the heparin tubes were
used immediately for in vitro incubation with amulti-antigen
vaccine and different doses of 1, 25(OH)
2
D
3
.
PBMC were isolated by density centrifugation on Ficoll-
Hypaque, Histopaque 1077 (Sigma Chemicals, Poole, UK).
The heparinized whole blood was diluted 1 : 1 with room
temperature 10mM phosphate buffered saline (PBS, Sigma
Chemicals, Poole, UK) and 20mL of diluted blood was
layered onto 10mL of room temperature Ficoll-Hypaque.
Samples were then centrifuged at 800 g for 30 minutes
at 20∘C. Cells were collected from interphase and washed
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Table 1: Physical characteristics of 43 athletes with high and low vitamin D status.
High-level vitamin D Low-level vitamin D 𝑃
Number (M : F) 18 (8 : 10) 25 (19 : 6)
Age (years) 20.9 ± 4.1 19.9 ± 2.0 0.294
Height (cm) 174.0 ± 10.1 177.0 ± 8.5 0.309
Weight (kg) 71.0 ± 13.5 73.3 ± 9.4 0.516
BMI (kg/m2) 23.3 ± 2.8 23.3 ± 1.8 0.960
Mean training loads (Mean MET-h/wk) 84.9 ± 46.2 64.0 ± 28.2 0.100
Data are mean ± SD.
M: male; F: female.
𝑃 value from independent 𝑡-test is shown in right hand column.
twice with RPMI 1640 medium (Sigma Chemicals, Poole,
UK) supplemented with 10% Fetal Bovine Serum (Sigma
Chemicals, Poole, UK) and then spun at 250 g for 10 minutes
at 20∘C. Subsequently, cells were resuspended in RPMI 1640
medium supplemented with 10% Fetal Bovine Serum. Cells
were counted in an automated cell counter and the number of
cells was adjusted to 2 × 106 cells/mL in RPMI 1640 medium
supplemented with 10% Fetal Bovine Serum.
2.2. Plasma 25(OH)D Measurements. In our previous vita-
min D study [7], 225 EDTA plasma samples were analysed
for 25(OH)D
3
and 25(OH)D
2
with a high pressure liquid
chromatography tandem mass spectrometer (Waters Acuity,
Manchester, UK) after a maximum of 10 months in storage
with no previous freeze-thaw cycles as described previously
[13]. Briefly, 25(OH)D
2
, 25(OH)D
3
, and deuterated internal
standard were extracted from plasma samples, following
protein precipitation, using isolute C18 solid phase extraction
cartridges. Potential interfering compounds were removed
by initial elution with 50% methanol followed by elution of
the vitamins using 10% tetrahydrofuran in acetonitrile. Dried
extracts were reconstituted prior to injection into a high per-
formance liquid chromatography tandemmass spectrometer
in the multiple reaction mode (MRM).TheMRM transitions
(𝑚/𝑧) used were 413.2 > 395.3, 401.1 > 383.3, and 407.5 >
107.2 for 25(OH)D
2
, 25(OH)D
3
, and hexa-deuterated(OH)D
3
(internal standard), respectively. Intra-assay CVs were <10%
across a working range of 2.5–624 nmol/L for both 25(OH)D
3
and 25(OH)D
2
. Measurements were performed in a labora-
tory (Norwich University Hospital, Norwich, UK) meeting
the performance target set by the Vitamin D External Quality
Assessment Scheme (DEQAS) Advisory Panel for 25(OH)D
assays.
2.3. In Vitro Incubation with 1, 25(OH)
2
D
3
and Multiantigen
Vaccine. The whole blood samples and PBMC were incu-
bated in vitro with a multi-antigen vaccine and different
doses of 1, 25(OH)
2
D
3
. The stimulant was a commercially
availablemulti-antigen vaccine (Pediacel Vaccine, Sanofi Pas-
teur, UK) containing diphtheria, tetanus, acellular pertussis,
poliomyelitis, and haemophilus influenzae type b antigens.
1, 25(OH)
2
D
3
was purchased from Sigma-Aldrich (Missouri,
USA) and dissolved in absolute ethanol to give a stock
solution of 10 𝜇M. Aliquots were subsequently diluted with
RPMI 1640 medium for use in the in vitro incubations.
Stimulated whole blood and PBMC culture production of
cytokines (IFN-𝛾, TNF-𝛼, IL-1𝛽, IL-2, IL-4, IL-6, and IL-10)
were determined as described previously [14]. Briefly, for the
determination of baseline unstimulated cytokine production,
0.25mL of heparinized whole blood or PBMC were added
to 0.75mL of RPMI 1640 medium and incubated at 37∘C
and 5% CO
2
for 24 h. Additionally, 0.25mL of heparinized
whole blood or PBMC were added to 0.70mL of RPMI 1640
medium containing different doses of 1, 25(OH)
2
D
3
(0, 100,
200, 1000, and 10000 pmol/L) with an added 50𝜇L of Pediacel
vaccine cocktail (Sanofi Pasteur msd Limited, Maidenhead,
UK) at a dilution of 1 : 100, before being incubated at 37∘C and
5% CO
2
for 24 h. The stimulant dilution of 1 : 100 used in this
studywas based on a separate experiment (unpublished data),
which established the dose-response curve for the measured
cytokines over the dilution range of 1 : 100–1 : 20 000. Samples
were then centrifuged at 13000 g for 4min at 4∘C, following
which the supernatant fluid was harvested and stored at
−80∘C prior to analysis of cytokine concentrations.
2.4. Cytokine Measurements. Cytokine concentrations were
determined using an Evidence Investigator System and the
high sensitivity cytokine biochip array EV3513 (Randox,
County Antrim, UK). The intra-assay CV for all measured
cytokines was less than 5.0%. The measured cytokine con-
centrations for the monocyte-derived cytokines (TNF-𝛼, IL-
1𝛽, and IL-6) and lymphocyte-derived cytokines (IL-2, IL-4,
and IFN-𝛾) were divided by the monocyte and lymphocyte
counts, respectively, to give cytokine production per 106 cells.
2.5. Statistical Analysis. The independent t-test was used to
test for the differences in the physical characteristics of par-
ticipants between high-level and low-level vitamin D groups.
Mann-Whitney U-test was used to test for the differences in
the circulating cytokine concentrations between high-level
and low-level vitamin D groups. The correlation between
circulating cytokine and plasma 25(OH)D concentrations
was determined using Spearman’s rank correlation.Wilcoxon
signed rank test performed in the previous studies by Khoo
and colleagues [11, 12] was also used in the present study to
examine for the differences in the stimulated whole blood
and PBMC culture production of cytokines between different
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Table 2: Circulating cytokine concentrations between high-level and low-level vitamin D status groups.
High-level vitamin D Low-level vitamin D 𝑃
IL-2 (pg/mL) 3.8 (2.6–4.5) 2.5 (0.0–5.4) 0.186
IL-4 (pg/mL) 1.9 (1.8–2.3) 1.8 (1.5–2.0) 0.127
IL-6 (pg/mL) 1.3 (1.0–1.9) 0.9 (0.7–1.5) 0.218
IL-10 (pg/mL) 0.7 (0.6–1.6) 0.6 (0.5–0.8) 0.020
IFN-𝛾 (pg/mL) 0.9 (0.6–1.4) 0.5 (0.0–0.7) 0.004
TNF-𝛼 (pg/mL) 2.6 (1.8–3.2) 2.4 (2.0–3.3) 0.825
IL-1𝛽 (pg/mL) 4.5 (3.3–5.7) 3.9 (2.8–7.2) 0.912
Data are median and IQR.
𝑃 value fromMann-Whitney 𝑈-test is shown in right hand column.
Table 3: The correlation between circulating cytokine and plasma 25(OH)D concentrations.
IL-2 IL-4 IL-6 IL-10 IFN-𝛾 TNF-𝛼 IL-1𝛽
Spearman’s rank correlation 0.179 0.197 0.126 0.257 0.374 −0.157 0.006
𝑃 value 0.250 0.206 0.421 0.097 0.014 0.314 0.970
doses of 1, 25(OH)
2
D
3
in vitro incubation. Differences in the
multi-antigen stimulated cytokine production without the
addition of 1, 25(OH)
2
D
3
by whole blood and PBMC cultures
were compared with the Mann-Whitney U test. Data are
presented as mean (±SD) or median and interquartile range
(IQR) and the accepted level of significance was 𝑃 < 0.05.
3. Results
3.1. Circulating Cytokine Concentrations and Vitamin D Sta-
tus. The plasma 25(OH)D concentrations were 101.3 ± 13.9
and 31.8 ± 3.5 nmol/L in the high-level and low-level vitamin
D status groups, respectively.The anti-inflammatory cytokine
IL-10 concentration in the high-level vitamin D status group
was marginally but significantly higher than in the low-level
group (𝑃 = 0.020), and the proinflammatory cytokine IFN-
𝛾 concentration in the high-level vitamin D status group
was substantially and significantly higher than in the low-
level group (𝑃 = 0.004) (Table 2). However, there was no
significant difference in the circulating TNF-𝛼, IL-1𝛽, IL-2,
IL-4, and IL-6 concentrations between high-level and low-
level vitamin D status groups (Table 2). In addition, there was
a positive correlation between the plasma 25(OH)D and IFN-
𝛾 concentrations (r = 0.374, P = 0.014), but plasma 25(OH)D
concentrations did not correlate with TNF-𝛼, IL-1𝛽, IL-2, IL-
4, IL-6, or IL-10 levels (Table 3).
3.2. Antigen-Stimulated Cytokine Production by Whole
Blood Culture. The antigen-stimulated production of the
monocyte-derived cytokines, TNF-𝛼 and IL-6, was both
attenuated by 1, 25(OH)
2
D
3
, but production of IL-1𝛽
was not significantly influenced by 1, 25(OH)
2
D
3
. The
production of TNF-𝛼 was significantly lower in the presence
of 1000 pmol/L and 10000 pmol/L of 1, 25(OH)
2
D
3
compared
with its production without the addition of 1, 25(OH)
2
D
3
and the production of IL-6 was significantly lower in
the presence of 10000 pmol/L of 1, 25(OH)
2
D
3
compared
with its production without the addition of 1, 25(OH)
2
D
3
(Figure 1). In addition, the antigen-stimulated production
of the lymphocyte-derived cytokines, IFN-𝛾 and IL-2,
was both attenuated by 1, 25(OH)
2
D
3
, but production of
IL-4 was not significantly influenced by 1, 25(OH)
2
D
3
.
The production of IL-2 was significantly lower in the
presence of 1000 pmol/L and 10000 pmol/L of 1, 25(OH)
2
D
3
compared with its production without the addition of 1,
25(OH)
2
D
3
and the production of IFN-𝛾 was significantly
lower in the presence of 10000 pmol/L of 1, 25(OH)
2
D
3
compared with its production without the addition of 1,
25(OH)
2
D
3
(Figure 1). The anti-inflammatory cytokine IL-10
is produced by both monocytes and lymphocytes, so it is
not appropriate to normalise its production by cell counts.
The production of IL-10 was significantly higher in the
presence of 10000 pmol/L of 1, 25(OH)
2
D
3
compared with its
production without the addition of 1, 25(OH)
2
D
3
(0 pmol/L:
1.5 ± 0.8 pg/mL; 10000 pmol/L: 4.5 ± 2.1 pg/mL; 𝑃 = 0.028),
but no differences were observed at the other concentration
of added 1, 25(OH)
2
D
3
.
3.3. Antigen-Stimulated Cytokine Production by PBMC Cul-
ture. The antigen-stimulated production of the monocyte-
derived cytokine, IL-6, was attenuated by 1, 25(OH)
2
D
3
,
but production of TNF-𝛼 and IL-1𝛽 was not significantly
influenced by 1, 25(OH)
2
D
3
. The production of IL-6 was
significantly lower in the presence of 10000 pmol/L of 1,
25(OH)
2
D
3
compared with its production without the addi-
tion of 1, 25(OH)
2
D
3
(Figure 2). However, the antigen-
stimulated production of the lymphocyte-derived cytokines,
IFN-𝛾, IL-2, and IL-4, was not significantly influenced by the
incubation of different doses of 1, 25(OH)
2
D
3
(Figure 2). In
addition, the production of IL-10 was also not significantly
influenced by 1, 25(OH)
2
D
3
.
3.4. Comparison of the Whole Blood and PBMC Culture.
The production of the lymphocyte-derived cytokines, IFN-𝛾,
IL-2, and IL-4, and the monocyte-derived cytokine, IL-1𝛽,
by multi-antigen stimulated whole blood culture without
ISRN Nutrition 5
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Figure 1: The antigen-stimulated production of the lymphocyte-derived cytokines (IL-2, IL-4, and IFN-𝛾 (a)) and the monocyte-derived
cytokines (IL-6, TNF-𝛼, and IL-1𝛽 (b)) by whole blood culture. ∗𝑃 < 0.05 versus 0 pmol/L. Ly: lymphocytes; Mo: monocytes.
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Figure 2: The antigen-stimulated production of the lymphocyte-derived cytokines (IL-2, IL-4, and IFN-𝛾 (a)) and the monocyte-derived
cytokines (IL-6, TNF-𝛼, and IL-1𝛽 (b)) by PBMC culture. ∗𝑃 < 0.05 versus 0 pmol/L. Ly: lymphocytes; Mo: monocytes.
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Table 4: Comparison of the whole blood and PBMC culture in antigen-stimulated cytokine production.
Whole blood PBMC 𝑃
IL-2 (pg/106 Ly) 9.5 (4.5–16.6) 0.3 (0.2–0.7) 0.016
IL-4 (pg/106 Ly) 1.0 (0.7–1.6) 0.4 (0.3–0.4) 0.025
IL-6 (pg/106 Mo) 48.9 (16.5–145.3) 15.4 (12.1–23.5) 0.262
IL-10 (pg/mL) 1.7 (1.5–1.8) 2.0 (1.6–2.3) 0.297
IFN-𝛾 (pg/106 Ly) 0.6 (0.3–0.9) 0.1 (0.0–0.1) 0.037
TNF-𝛼 (pg/106 Mo) 8.4 (3.6–11.9) 7.7 (6.4–11.7) 0.631
IL-1𝛽 (pg/106 Mo) 6.4 (4.3–8.8) 1.6 (1.3–2.6) 0.037
Data are median and IQR.
Ly: lymphocytes; Mo: monocytes.
𝑃 value fromMann-Whitney 𝑈-test is shown in right hand column.
the addition of 1, 25(OH)
2
D
3
was significantly higher than
their respective production by the PBMC culture (Table 4).
However, there was no significant difference in the antigen-
stimulated production of TNF-𝛼, IL-6, and IL-10 between the
whole blood and PBMC cultures (Table 4).
4. Discussion
The aims of this research were to determine the influence of
plasma 25(OH)D status on the circulating cytokine levels in
endurance sport athletes and the effects of different doses of
1, 25(OH)
2
D
3
on the multi-antigen stimulated cytokine pro-
duction by whole blood and PBMC cultures. The main find-
ings of the present study were that the circulating IL-10 and
IFN-𝛾 concentrationswere significantly higher in the vitamin
D sufficient athletes comparedwith the vitaminD insufficient
athletes and there was a positive correlation between the
plasma 25(OH)D and IFN-𝛾 concentrations in endurance
athletes. Furthermore, the production of TNF-𝛼, IL-6, IFN-
𝛾, IL-2, and IL-10 by multi-antigen stimulated whole blood
culture was significantly influenced by 1, 25(OH)
2
D
3
of
concentrations of 1000 pmol/L and/or 10000 pmol/L. Never-
theless, a similar effect was only observed for the production
of IL-6 by multi-antigen stimulated PBMC culture. In addi-
tion, the production of lymphocyte-derived and monocyte-
derived cytokines, such as IFN-𝛾, IL-2, IL-4, and IL-1𝛽, was
significantly different in the multi-antigen stimulated whole
blood culturewithout the addition of 1, 25(OH)
2
D
3
compared
with its production in the PBMC culture.
On the basis of the present data, we found that the circu-
lating IL-10 and IFN-𝛾 concentrations in the vitamin D suf-
ficient athletes were significantly higher than in the vitamin
D insufficient athletes and there was a positive correlation
between the plasma 25(OH)D and IFN-𝛾 concentrations in
endurance athletes. In contrast, a previous study has reported
an elevation of circulating proinflammatory cytokines in
vitamin D insufficient adults [9]. Barker et al. [9] indicated
that circulating proinflammatory cytokine concentrations,
such as TNF-𝛼, IFN-𝛾, IL-1𝛽, and IL-2, were significantly
higher in vitamin D insufficient compared to vitamin D
sufficient adults but the anti-inflammatory cytokine, IL-10,
was not significantly different between vitamin D insufficient
and sufficient adults. Moreover, Barker and colleagues [9]
found an inverse correlation between the plasma 25(OH)D
and IFN-𝛾 concentrations. The reason for this discrepancy is
still unclear but may be due to the difference of the cut-off
point used for vitamin D insufficiency in the two studies. In
healthy humans, plasma 25(OH)D serum levels > 100 nmol/L
are defined as optimal vitamin D status and levels from 50 to
100 nmol/L are defined as adequate. Serum levels of 25(OH)D
< 50 nmol/L are proposed to define inadequate vitamin D
status and values < 30 nmol/L represent vitamin D deficiency
[2]. Therefore, the commonly used cut-off point for vitamin
D insufficiency in clinical practice and research reports is
the threshold concentration of 25(OH)D of < 50 nmol/L
[15]. However, the cut-off point for vitamin D insufficiency
used in the Barker et al. [9] study was < 80 nmol/L and
the average serum 25(OH)D concentration of vitamin D of
insufficient adults was around 60 nmol/L. Thus, the vitamin
D insufficient adults in their study were not even close to
being vitamin D deficient. In addition, another confounding
factor may be due to the anti-inflammatory effects of exercise
training. The participants recruited in our previous vitamin
D study [7] were the endurance sport athletes engaged
in regular sports training (predominantly endurance-based
activities such as running, cycling, swimming, triathlon,
team games, and racquet sports) and their self-reported
training loads averaged 10 h/week. The anti-inflammatory
effects of exercise training on cytokine responses, such
as the release of IL-6 from contracting muscle and the
increased levels of circulating IL-10, cortisol, and adrenaline,
are discussed in the review article by Gleeson et al. [10].
It has been demonstrated that the active skeletal muscle
significantly increases both cellular and circulating levels of
IL-6 during and following exercise of sufficient load and
the transient rise in circulating IL-6 during exercise appears
to be responsible for a subsequent rise in circulating levels
of anti-inflammatory cytokines, including IL-10, which is a
potent promoter of an anti-inflammatory state [10]. Increases
in circulating cortisol and adrenaline during exercise are
due to activation of the hypothalamic-pituitary-adrenal axis
and the sympathetic nervous system, respectively. Cortisol
is known to have potent anti-inflammatory effects and also
augmented by the rise in circulating IL-6 from contracting
skeletal muscle [10]. Therefore, the influence of vitamin D on
circulating cytokines might be different between athletes and
nonathletes. Further research is still needed to understand
8 ISRN Nutrition
the influence of vitamin D on circulating cytokines between
athletes and nonathletes.
The finding of higher circulating IFN-𝛾 concentrations in
the vitamin D sufficient athletes and a positive correlation
between the plasma 25(OH)D and IFN-𝛾 concentrations in
the present study might be helpful to support the arguments
that vitamin D could play a role in reducing both the severity
and duration of upper respiratory tract illness symptoms
in our previous vitamin D study [7]. It has been reported
that increasing IFN-𝛾, in the circulation contributes to the
conversion of 25(OH)D to its active hormonal form, 1,
25(OH)
2
D, in the circulation during inflammatory stress in
humans [16]. 1, 25(OH)
2
D has a vital role in upregulating
the production of antimicrobial proteins and peptides, such
as cathelicidin and 𝛽-defensin, which are produced by both
epithelial cells and macrophages and have a broad range
of activities against microorganisms including the direct
inactivation of viruses [17] and the hormone also acts to
maintain a balance between inflammatory Th1/Th17 cells
and immunosuppressive Th2/regulatory T cells to temper
inflammation and tissue damage [18]. Therefore, the vitamin
D sufficient athletes with higher circulating IFN-𝛾 concen-
trations may have less severe symptoms and shorter duration
when the upper respiratory tract illness is present.
According to the findings from the present study, it seems
likely that the multi-antigen stimulated cytokine production
by whole blood culture was influenced by 1, 25(OH)
2
D
3
only
in concentrations that were 1000 pmol/L or more. Although
the production of proinflammatory cytokines, TNF-𝛼, IL-
6, IFN-𝛾 and IL-2 by multi-antigen stimulated whole blood
culture was significantly lower in the presence of 1000 pmol/L
or 10000 pmol/L of 1, 25(OH)
2
D
3
and the production of
anti-inflammatory cytokine, IL-10, was significantly higher
in the presence of 10000 pmol/L of 1, 25(OH)
2
D
3
, we found
that both proinflammatory and anti-inflammatory cytokine
production by multi-antigen stimulated whole blood culture
were not influenced by 1, 25(OH)
2
D
3
in added concen-
trations of 100 pmol/L and 200 pmol/L. In contrast, the
results from our previous study [7] showed that vitamin D
status (determined by plasma levels of 25(OH)D) did signifi-
cantly influence lymphocyte andmonocyte proinflammatory
cytokine production by antigen-stimulated whole blood cul-
ture. Individuals with high levels of plasma 25(OH)D would
be expected to have higher levels of 1, 25(OH)
2
D, so it is
perhaps surprising that in the in vitro situation variations in
1, 25(OH)
2
Dwithin the normal physiological range appear to
have no significant effect on leukocyte cytokine production.
In healthy humans, normal concentrations of circulating
1, 25(OH)
2
D are approximately 50–250 pmol/L, about 1000
times lower than its precursor, 25(OH)D [3]. Inhibition of
proinflammatory cytokine production and elevation of anti-
inflammatory cytokine production in the present study were
only observed when the whole blood was incubated with
1, 25(OH)
2
D in concentrations that were 10–100-fold above
the normal healthy range for plasma 1, 25(OH)
2
D.Therefore,
the physiological relevance is unclear. A limitation of the
present study is that the participants’ plasma concentration
of 1, 25(OH)
2
D was not determined. Further research is still
needed to understand the influence of the normal healthy
range of plasma 1, 25(OH)
2
Don themulti-antigen stimulated
cytokine production by whole blood culture.
The data from our study show that there was a significant
difference in the production of multi-antigen stimulated
lymphocyte-derived and monocyte-derived cytokines, such
as IFN-𝛾, IL-2, IL-4, and IL-1𝛽, between the whole blood and
PBMC cultures and it seems likely that there was a better
dose-dependent response in the cytokine production of
multi-antigen stimulated whole blood culture with different
doses of 1, 25(OH)
2
D
3
than in the PBMC culture. The whole
blood culture retains the normal cellular, hormonal, and
cytokine milieu that the leukocytes are normally exposed to
in the circulation. This model probably comes closest to the
natural environment avoiding artefacts from cell isolation
and preparation and allowing natural interactions between
immune components and antigens within the normal hor-
monalmilieu. Essentially it is an in vitromethod of simulating
responses to an infection. Moreover, the stimulant we used
was a vaccine containing antigens from a virus and both
gram-positive and gram-negative bacteria and the multiple
antigen challenge used in the present study provides valuable
information on cytokine production since not all cytokines
respond to the same antigen. The capacity of leukocytes
to produce cytokines upon adequate challenge (e.g., with
mitogen, antigen, endotoxin, or pathogen exposure) has
potentially far reaching consequences for the entire func-
tional capacity of the immune system. Therefore, the whole
blood culture stimulated with multi-antigen is highly likely
to reflect the capacity of an individual to defend itself against
intruding microorganisms.
In conclusion, the present study demonstrated that the
influence of vitamin D on circulating cytokines might be
different in athletes compared with previous studies on
nonathletes and the higher circulating IFN-𝛾 concentrations
in vitamin D sufficient athletes might be helpful to support
the arguments that vitamin D could play a role in reducing
both the severity and duration of upper respiratory tract
illness symptoms. In addition, we found that both proinflam-
matory and anti-inflammatory cytokines by multi-antigen
stimulated whole blood culture were not influenced by 1,
25(OH)
2
D
3
in concentrations within the normal healthy
range. Furthermore, the whole blood culture stimulated with
multi-antigenmight be a better in vitromethod of simulating
responses to an infection than cultures using PBMCs.
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